Map the devices
We profiled current devices offering painless blood collection and the players behind them.
A global medical device manufacturer wanted to understand innovation in decentralized clinical trials beyond classic blood workflows. We assessed the market, leading players and self-sampling devices, and tested trends with experts.
The client is a global medical device manufacturer. It wanted to understand the prospects for at-home collection and patient-centric workflows.
Prescouter was asked to map current and future trends in decentralized clinical trials and the leading players developing alternative blood workflows, such as devices for sample self-collection, stabilization and processing.
Current and future DCT trends.
Painless at-home blood sampling.
Collection built around the patient.
We profiled current devices offering painless blood collection and the players behind them.
Patent research revealed similarities and innovations among current technologies.
Interviews confirmed secondary trends and surfaced challenges from the customer perspective.
Prescouter delivered an overview of the DCT market opportunity and leading contract research organizations, expert views on blood self-sampling, a landscape of device developers and a comparison of their technical advances. It closed with the customer view on device preferences and unmet needs.
With leading CROs in the DCT space.
Self-sampling players compared.
Device preferences from the user side.
Decentralized trials change who collects samples and where. Device makers that design for the patient at home will be ready as trials move.
Size the market, compare the players and hear what customers need. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]Pick a time on our calendar right now.
If you’d like to know the outcome of your submission, please leave your email address